Joy Ackles
Payments from drug & device makers
Across 222 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$705
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$557
- Amgen$468
- GSK$344
- Novo Nordisk$309
- AstraZeneca$278
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,935100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $705 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $557 |
| Amgen | 24 | $468 |
| GSK | 19 | $344 |
| Novo Nordisk | 24 | $309 |
| AstraZeneca | 16 | $278 |
| Daiichi Sankyo Inc. | 9 | $192 |
| Pfizer | 8 | $172 |
| Boehringer Ingelheim | 7 | $135 |
| Exact Sciences | 5 | $102 |
| Lilly USA, LLC | 4 | $91 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $89 |
| Amarin Pharma, Inc. | 4 | $75 |
| Merck | 3 | $62 |
| Corcept Therapeutics | 2 | $46 |
| Bayer | 2 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Vertex | 1 | $32 |
| Tandem Diabetes Care, Inc. | 1 | $29 |
| Phadia US Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Medtronic | 1 | $20 |
| Mylan Specialty L.p. | 1 | $19 |
| Nevro Corp. | 1 | $19 |
| Edwards Lifesciences | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $13 |
How this compares
$3,935 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 148 | $174,021 |
| MounjaroTirzepatide | 75 | $78,792 |
| JardianceEmpagliflozin | 59 | $63,624 |
| EliquisApixaban | 70 | $54,652 |
| CreonLipase/Protease/Amylase | 11 | $13,773 |
| FarxigaDapagliflozin Propanediol | 12 | $12,967 |
| TrulicityDulaglutide | 12 | $10,553 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $8,461 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $7,359 |
| SynthroidLevothyroxine Sodium | 89 | $6,394 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,162 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $4,309 |
| Atorvastatin Calcium | 512 | $4,236 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $3,797 |
| Levothyroxine Sodium | 318 | $3,486 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $309 | $174,021148 claims |
| Lilly USA, LLCMounjaro, Trulicity | $91 | $89,34587 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $135 | $69,78771 claims |
| PfizerEliquis | $172 | $54,65270 claims |
| AbbVieCreon, Synthroid, Armour Thyroid | $705 | $21,498115 claims |
| AstraZenecaFarxiga, Symbicort | $278 | $15,77325 claims |
| GSKTrelegy Ellipta | $344 | $8,46115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in Chico
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.